Osiris Therapeutics (OSIR)
Osiris Therapeutics Revenues: 1.137M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
OSIR Revenues Rankings
| Overall | 2nd percentile | 4315 of 4432 |
| Sector | 12th percentile | 414 of 471 in Healthcare |
| Industry | 21st percentile | 104 of 132 in Biotechnology |
OSIR Revenues Range, Past 5 Years
| Minimum | 0.037M | Mar 2011 |
| Maximum | 1.137M | Mar 2012 |
| Average | 0.369M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these OSIR related companies
OSIR News
Unusual 11 Mid-Day Movers 05/31: (TLB) (CFK) (NEBS) Higher; (CHTP) (HMPR) (SMI) Lower
May 31, 1:07PM Street Insider
May 31, 1:07PM Street Insider
Morning Movers 05/31: (TLB) (CFK) (NEBS) (BONT) Higher; (CHTP) (AONE) (NCIT) (NBG) Lower
May 31, 11:09AM Street Insider
May 31, 11:09AM Street Insider
Vishay Intertechnology, The Fresh Market Included in Stocks Up on High Volume Wednesday
May 30, 12:33PM Fox Business
May 30, 12:33PM Fox Business
Morning Movers 05/30: (BAH) (TFM) (DGIT) Higher; (PBY) (TEA) (SURG) (PWRD) (MAGS) Lower
May 30, 11:20AM Street Insider
May 30, 11:20AM Street Insider
$OSIR spike on news of pass-through status for Grafix under Medicare's outpatient prospective payment system. http://stks.co/41yA
about a day ago by abubnic
about a day ago by abubnic
Pre-Open Movers 5/30: (NEON) (OSIR) (MON) Higher; (PBY) (PWRD) (RIMM) Lower (more...)
May 30, 9:37AM Street Insider
May 30, 9:37AM Street Insider
Osiris Therapeutics (OSIR) Wins Medicare Reimbursement Codes for Grafix
May 29, 5:13PM Street Insider
May 29, 5:13PM Street Insider
Large Pharmaceuticals Look to Biotech Industry to Provide New Streams of Revenue
May 23, 8:20AM Marketwire
May 23, 8:20AM Marketwire
@epime7heus $OSIR moved up fast. Broke over trigger @ 6.45 and hit 6.55 (tweet point) fast. 1st possible support point was 6.45, 2nd 6.36
about 9 days ago by StockHorizon
about 9 days ago by StockHorizon
6 breakouts: $OSIR (stop: $5.69). Two sub-$1 stocks. For a rally off a bottom it was a little disappointing not to see more here.
about 10 days ago by fallondpicks
about 10 days ago by fallondpicks
Osiris Therapeutics (OSIR) Volatility Up as Shares Move to 10-Month High
May 21, 1:40PM Street Insider
May 21, 1:40PM Street Insider
Salesforce.com, Winnebago Industries Included in Stocks Up on High Volume Friday
May 18, 12:32PM Fox Business
May 18, 12:32PM Fox Business
Osiris (OSIR) Wins Marketing Clearance for Prochymal from Health Canada
May 17, 4:47PM Street Insider
May 17, 4:47PM Street Insider
Listen to $OSIR Q1 2012 earnings call - live at 09:00 AM, ondemand after - http://stks.co/3mkR
about 20 days ago by earningscast
about 20 days ago by earningscast
Trading Radar for 05/11: Gordmans (GMAN), Dr. Reddys (RDY), Cache (CACH), Osiris Therapeutics (OSIR) Report
May 10, 5:52PM Street Insider
May 10, 5:52PM Street Insider
Osiris Therapeutics Announces First Quarter 2012 Financial Results Conference Call
May 03, 5:00PM Business Wire
May 03, 5:00PM Business Wire
Avoid Osiris Therapeutics $OSIR $QQQ $IWM $$ #biotech #KSMT http://stks.co/2rhR via @jnapodano
about 78 days ago by MichaelKudrna
about 78 days ago by MichaelKudrna
Listen to $OSIR Q4 2011 earnings call - live at 09:00 AM, ondemand after - http://stks.co/2l3X
about 83 days ago by earningscast
about 83 days ago by earningscast
$OSIR will report its financial results for Q4 and full year on Friday, March 9. Webcast @ 9am. http://stks.co/2f07
about 89 days ago by abubnic
about 89 days ago by abubnic
Here's explanation we waited for yesterday: $OSIR Provides Update On Sanofi Deal. http://stks.co/2MBd
about 111 days ago by abubnic
about 111 days ago by abubnic
No word from $OSIR CEO on whether Sanofi action is
a cost-saving initiative or if they have plans to
dissolve other Osiris/Sanofi programs.
about 112 days ago by abubnic
about 112 days ago by abubnic
$OSIR drops after Sanofi discontinues P3 GvHD Program. http://stks.co/2KlB
about 112 days ago by abubnic
about 112 days ago by abubnic
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| OSIR | 6.31 | -0.67 | -9.60% | 229.15M |
| OSHC | 11.98 | -0.02 | -0.17% | 87.48M |
| OSG | 10.93 | -0.08 | -0.73% | 335.25M |
| OSBC | 1.33 | +0.07 | +5.56% | 17.74M |
| ORRF | 7.55 | +0.03 | +0.40% | 60.61M |
| ORLY | 95.95 | +0.23 | +0.24% | 12.16B |
| ORI | 9.88 | +0.00 | +0.00% | 2.562B |
| OREX | 3.345 | -0.07 | -2.19% | 231.67M |
| SWX | 41.97 | +0.23 | +0.55% | 1.924B |
| SWU | 117.64 | +0.51 | +0.44% |
